XB-002

N/A

Report date: 2025/12/05 09:24:17

Base Information

Drug NameXB-002
Drug Alias NameXB-002ICON-2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionTissue factor inhibitors
TargetsTissue factor
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantUterine Cervical Neoplasms +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIconic Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesZymeworks IncExelixis Inc
Inactive CompaniesIconic Therapeutics Inc
Active IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantUterine Cervical Neoplasms +[12] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A